Secondary Logo

Journal Logo

Published Ahead-of-Print - Last Updated: June 12, 2019

The editors of this journal are pleased to offer electronic publication of accepted papers prior to print publication. These papers can be cited using the date of access and the unique DOI number. Any final changes in manuscripts will be made at the time of print publication and will be reflected in the final electronic version of the issue.

Disclaimer: Articles appearing in this Published Ahead-of-Print section have been peer-reviewed and accepted for publication in this journal and posted online before print publication. Articles appearing here may contain statements, opinions, and information that have errors in facts, figures, or interpretation. Accordingly, Lippincott Williams & Wilkins, the editors and authors and their respective employees are not responsible or liable for the use of any such inaccurate or misleading data, opinion or information contained in the articles in this section.

Published Ahead-of-Print Articles are available in PDF format only.


PDF Only


Evolutionarily conserved resistance to phagocytosis observed in melanoma cells is insensitive to upregulation of pro-phagocytic signals and to CD47 blockade

Anderson, Katie L.; Snyder, Kristin M.; Ito, Daisuke; More

Melanoma Research. ., Post Author Corrections: June 12, 2019

Neuroblastoma RAS viral oncogene homolog mRNA is differentially spliced to give five distinct isoforms implications for melanoma therapy

Duggan, Megan C.; Regan-Fendt, Kelly; Olaverria Salavaggione, Gonzalo N.; More

Melanoma Research. ., Post Author Corrections: May 20, 2019

Nivolumab for patients with metastatic uveal melanoma previously untreated with ipilimumab a single-institution retrospective study

Namikawa, Kenjiro; Takahashi, Akira; Mori, Taisuke; More

Melanoma Research. ., Post Author Corrections: May 14, 2019

Effectiveness of dabrafenib in the treatment of patients with BRAF V600–mutated metastatic melanoma in a Named Patient Program

Martin-Algarra, Salvador; Hinshelwood, Rebecca; Mesnage, Soizick; More

Melanoma Research. ., Post Author Corrections: May 14, 2019

Chondroitin sulfate proteoglycan 4 enhanced melanoma motility and growth requires a cysteine in the core protein transmembrane domain

Yang, Jianbo; Price, Matthew A.; Wanshura, Leah E.C.; More

Melanoma Research. ., Post Author Corrections: February 01, 2019

Immunotargeted therapy in melanoma patient, provider preferences, and willingness to pay at an academic cancer center

Stenehjem, David D.; Au, Trang H.; Ngorsuraches, Surachat; More

Melanoma Research. ., Post Author Corrections: January 25, 2019

Time trends and age–period–cohort analysis of cutaneous malignant melanoma incidence rates in the Romagna Region (northern Italy), 1986–2014

Mancini, Silvia; Crocetti, Emanuele; Bucchi, Lauro; More

Melanoma Research. ., Post Author Corrections: January 04, 2019

Prognostic significance of distant metastasis-free interval in patients with relapsed melanoma treated with BRAF with or without MEK inhibitors

Bafaloukos, Dimitrios; Papaxoinis, George; Linardou, Helena; More

Melanoma Research. ., Post Author Corrections: December 28, 2018

Recurrence risk of early-stage melanoma of the external ear an investigation of surgical approach and sentinel lymph node status

Truong, Amanda; Hyngstrom, John R.; Andtbacka, Robert H.I.; More

Melanoma Research. ., Post Author Corrections: December 20, 2018

A meta-analysis of melanoma risk in industrial workers

Vujic, Igor; Gandini, Sara; Stanganelli, Ignazio; More

Melanoma Research. ., Post Author Corrections: October 26, 2018


PDF Only


Semaphorin-5A downregulation is associated with enhanced migration and invasion of BRAF-positive melanoma cells under vemurafenib treatment in melanomas with heterogeneous BRAF status

Komina, Anna V.; Palkina, Nadezhda V.; Aksenenko, Mariya B.; More

Melanoma Research. ., Post Author Corrections: May 20, 2019


PDF Only



PDF Only


Show: